FIGURE

Fig. 1

ID

ZDB-FIG-240722-1

Publication

Crespo et al., 2024 - The PP2A regulator IER5L supports prostate cancer progression

Other Figures

All Figure Page

Back to All Figure Page

Fig. 1

IER5L is upregulated in metastatic prostate cancer. a Violin plots depicting the Log2 expression of IER5L in non-tumoral (N), prostate cancer (PCa), lung adenocarcinoma (LUAD) and colorectal cancer (CRC) specimens in the indicated dataset. p-value derives from a Student’s t-test analysis between the indicated groups. b Violin plots showing the Log2 expression of IER5L mRNA in primary tumor (PT) and metastatic (M) PCa specimens. p-value derives from a Student’s t-test analysis between the indicated groups. c Kaplan-Meyer curves showing the association of IER5L mRNA expression to disease-free survival (DFS) in the indicated datasets. Quartile 1 (blue) and quartile 4 (green) are represented. A log-rank test p-value and the hazard ratio (HR) between two groups calculated by Cox proportional hazard model regression are provided above each graph

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cell Death Dis.